4.6 Article

A Tec kinase BTK inhibitor ibrutinib promotes maturation and activation of dendritic cells

Related references

Note: Only part of the references are listed.
Review Immunology

Targets for Ibrutinib Beyond B Cell Malignancies

A. Berglof et al.

SCANDINAVIAN JOURNAL OF IMMUNOLOGY (2015)

Review Oncology

Viral infections and their management in patients with chronic lymphocytic leukemia

Thomas Melchardt et al.

LEUKEMIA & LYMPHOMA (2013)

Review Immunology

Dendritic cells and other innate determinants of T helper cell polarisation

Kevin P. Walsh et al.

TRENDS IN IMMUNOLOGY (2013)

Review Oncology

Cancer immunotherapy via dendritic cells

Karolina Palucka et al.

NATURE REVIEWS CANCER (2012)

Article Biotechnology & Applied Microbiology

The Unexpected Role for the Aryl Hydrocarbon Receptor on Susceptibility to Experimental Toxoplasmosis

Yuriko Sanchez et al.

JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)

Article Medicine, General & Internal

The immunodeficiency of chronic lymphocytic leukaemia

A. D. Hamblin et al.

BRITISH MEDICAL BULLETIN (2008)

Article Immunology

Notch-RBP-J signaling controls the homeostasis of CD8- dendritic cells in the spleen

Michele L. Caton et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2007)

Article Multidisciplinary Sciences

Regulation of dendritic cell maturation and function by Bruton's tyrosine kinase via IL-10 and Stat3

Y Kawakami et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)